(GHYB) Goldman Sachs Access High - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814304537 • High Yield Bond
GHYB: High, Yield, Corporate, Bonds, USD
Goldman Sachs Access High Yield Corporate Bond ETF (NYSE ARCA: GHYB) is designed to provide exposure to the U.S. high-yield corporate bond market. The fund invests at least 80% of its assets in securities from its underlying index, which is based on the FTSE US High-Yield Market Index. This index incorporates concepts developed by Goldman Sachs Asset Management (GSAM) to enhance yield and credit exposure while maintaining liquidity.
GHYB offers a targeted approach to high-yield bonds, focusing on issuers with lower credit ratings but higher yields compared to investment-grade debt. The ETFs underlying index is constructed to include a broad range of high-yield bonds, providing diversification across various sectors and issuers. The fund is structured to deliver a high level of income while managing credit risk through diversification and index-based selection.
The ETF trades on the NYSE ARCA with the ticker symbol GHYB, offering investors access to the high-yield bond market through a liquid and transparent vehicle. With an average daily trading volume of 8,603 shares over the past 20 days, GHYB provides manageable liquidity for investors seeking to allocate to high-yield bonds. The funds assets under management (AUM) stand at $144.23 million, indicating a modest but established presence in the ETF market.
From a technical perspective, GHYB is trading at $44.85, slightly above its 20-day SMA of $44.78 and 50-day SMA of $44.45. The 200-day SMA of $43.46 suggests the fund has been in an upward trend over the longer term. The Average True Range (ATR) of 0.18 indicates relatively low volatility, making it a stable choice for income-focused investors.
Over the next three months, GHYB is expected to remain range-bound, with potential upside driven by stable credit conditions and continued demand for high-yield bonds. Based on its current SMA levels and ATR, the fund could trade between $44.20 and $45.50. Support is likely to hold near the 200-day SMA at $43.46, while resistance may emerge near $45.80, based on historical price patterns.
Additional Sources for GHYB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GHYB ETF Overview
Market Cap in USD | 146m |
Category | High Yield Bond |
TER | 0.34% |
IPO / Inception | 2017-09-05 |
GHYB ETF Ratings
Growth 5y | 58.4% |
Fundamental | - |
Dividend | 77.1% |
Rel. Strength Industry | 7.54 |
Analysts | - |
Fair Price Momentum | 45.43 USD |
Fair Price DCF | - |
GHYB Dividends
Dividend Yield 12m | 6.82% |
Yield on Cost 5y | 9.30% |
Annual Growth 5y | 4.32% |
Payout Consistency | 96.7% |
GHYB Growth Ratios
Growth Correlation 3m | 76.8% |
Growth Correlation 12m | 96.6% |
Growth Correlation 5y | 53.7% |
CAGR 5y | 6.58% |
CAGR/Max DD 5y | 0.41 |
Sharpe Ratio 12m | 1.71 |
Alpha | 3.13 |
Beta | 0.20 |
Volatility | 4.50% |
Current Volume | 9.9k |
Average Volume 20d | 7.7k |
As of March 15, 2025, the stock is trading at USD 44.48 with a total of 9,874 shares traded.
Over the past week, the price has changed by -0.81%, over one month by -0.64%, over three months by +0.36% and over the past year by +8.63%.
Partly, yes. Based on ValueRay Analyses, Goldman Sachs Access High (NYSE ARCA:GHYB) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.39 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GHYB as of March 2025 is 45.43. This means that GHYB is currently overvalued and has a potential downside of 2.14%.
Goldman Sachs Access High has no consensus analysts rating.
According to ValueRays Forecast Model, GHYB Goldman Sachs Access High will be worth about 49.4 in March 2026. The stock is currently trading at 44.48. This means that the stock has a potential upside of +11.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 49.4 | 11% |